Digital Content 
NEWS #PharmaBuzz
https://www.raps.org/news-and-articles/news-articles/2018/3/merck,-j-j-and-allergan-seek-changes-on-fda-draft
03 Dec 2015
// PR NEWS WIRE
http://www.prnewswire.com/news-releases/abbvie-announces-fda-acceptance-of-new-drug-application-for-a-once-daily-formulation-of-viekira-pak-ombitasvir-paritaprevir-and-ritonavir-tablets-dasabuvir-tablets-to-treat-genotype-1-chronic-hepatitis-c-virus-infection-300186528.html
01 Oct 2015
// PR NEWSWIRE
http://www.prnewswire.co.uk/news-releases/abbvie-demonstrates-commitment-to-hepatitis-c-patients-with-new-data-on-viekira-pak-ombitasvir-paritaprevir-ritonavir-tablets-dasabuvir-tablets-and-ongoing-clinical-development-program-at-the-liver-meeting-2015-530280381.html
28 Sep 2015
// PR NEWS WIRE
http://www.prnewswire.com/news-releases/abbvies-viekirax-ombitasvirparitaprevirritonavir-tablets-receives-approval-in-japan-for-the-treatment-of-genotype-1-chronic-hepatitis-c-300149653.html
12 Jun 2015
// Selina Mckee PHARMATIMES
http://www.pharmatimes.com/Article/15-06-10/NHS_England_stumps_up_%C2%A3190m_for_hep_C_therapy.aspx
20 May 2015
// Eric Palmer FIERCE PHARMA
http://www.fiercepharma.com/story/hep-c-landscape-shifts-again-bms-combo-nabs-breakthrough-tag/2015-05-20
Share 